NCT07364877

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421 and DW4421S in Healthy Adult Volunteers

• Status: Enrolling By Invitation
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 38 (estimated)
• Sponsor: Daewon Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Conditions

• Healthy Adult Volunteer

Interventions

Type	Name	Description
DRUG	DW4421	DW4421 or DW4421S
DRUG	DW4421S	DW4421 or DW4421S

Timeline

• Start date: 2025-12-28
• Primary completion: 2026-03-19
• Completion: 2026-05-18
• First posted: 2026-01-23
• Last updated: 2026-01-23

Locations

1 site across 1 country: South Korea